THURSDAY, Nov. 14, 2024 (HealthDay News) — Periodontal (gum) disease and diabetes are locked in a grim partnership aimed at undermining your health, experts warn. “Recent research has shown that diabetes is not only a major risk factor for periodontitis but that the relationship between the two conditions is bidirectional,Continue Reading

WEDNESDAY, Nov. 13, 2024 (HealthDay News) — The blockbuster GLP-1 drug semaglutide (Ozempic, Wegovy) could curb drinking for people battling alcohol use disorder, helping them to avoid crises that require hospitalization, new research shows. Numerous studies had already hinted that semaglutide might act on appetite centers in the brain toContinue Reading